-
Putin denies plan for new Russia military call up
-
Grief on Chinese internet as wait for Tibet flood news drags on
-
Caruana Galizia: 'one-woman WikiLeaks' who exposed Malta's shady side
-
Heavy rain puts a dampener on Taiwan 'extreme heat' drill
-
Kuwait's Iranians under pressure since start of war
-
Juve's Khephren Thuram out until 2027 with knee injury
-
EU lawmakers demand Brussels force Meta to 'protect' European children
-
Delivering aid to Nepal flood survivors 'very, very difficult': UN
-
Clooney turns AFP photographer in jokey red carpet switch
-
German growth prospects brighten as economy defies Mideast turmoil
-
Retirement Income Planning Florida Launches No-Cost 'Income Gap Analysis' Program for Pre-Retirees
-
Outrage mounts in Malta after acquittal over journalist's murder
-
Iraola hails Barcola mentality after blockbuster Liverpool move
-
Malaysia starts cloud seeding to help clear toxic haze
-
Michelsen shocks Nakashima in US Open clash of rising Americans
-
El Nino could be strongest in decades, UN warns
-
US govt sides with OpenAI in New York Times copyright lawsuit
-
Kenya steps up crocodile hunt as rising lakes fuel conflict
-
Grammy-Winning Jazz Vocalist Cassandra Wilson Dies at 70
-
Argentine Groups Seek Court Halt to Sea Lion Oil Project Near Falklands
-
Maui Wildfire Survivors Report Major Losses to Troubled Rebuilding Contractors
-
China’s Oil Use Drops 9 Percent as Transport Electrification Accelerates
-
WMO Says Powerful El Niño Is Likely to Persist Into February 2027
-
Fifth-Generation Mitsubishi Pajero Returns With Ladder Frame and Seven Seats
-
Honda Presses Suppliers for Deep Cost Cuts in $9.4 Billion Savings Drive
-
Philadelphia Roundup: Museum Closure, Phishing Warning and Gun Violence Data
-
Philadelphia Festival Revisits the Signing and Legacy of the U.S. Constitution
-
Philadelphia Natural History Museum Prepares to Close After Two Centuries
-
Russia to close branches of Germany's Goethe Institute
-
Indonesia protesters targeted by coordinated disinfo
-
Spacecraft bound for Mercury faces 'tricky' arrival
-
Oil sinks, bond yields ease and stocks boosted after Trump Iran hint
-
Philippines holds drills to safeguard students from armed intruders
-
American jazz singer Cassandra Wilson dies at 70
-
In Ghana, larger-than-life coffins tell the stories of the dead
-
Rare trio of Pacific hurricanes fueled by historic El Nino
-
Menoncello, Reece headline Top 14 new-season signings
-
Chinese WNBA star out of World Cup after losing passport
-
Families descend on Nepal in search of missing tourists
-
Medieval Europe and Africa collide in Sao Tome traditional theatre
-
Far-right AfD eyes huge win in east German state vote
-
Iran attacks US targets despite Trump threats
-
Brazil-Japan to play World Cup rematch at Singapore tournament
-
Alcaraz believes 'impossible' schedule raising injury threat
-
Defence chiefs back boosting US military presence in Australia
-
Alcaraz rallies to reach US Open third round, Sabalenka storms through
-
Nepal seeks climate justice after Himalayan disaster
-
Alcaraz overpowers Faria to reach US Open third round
-
Stocks rise, yields ease as oil slips on Trump hint at short bombing campaign
-
Hamilton hopes to boost title bid with record Italian triumph
Featured
Last news
ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide
Beyond Awareness to Bold Action - ESSE Care Launches #BeyondEndoAwareness Initiative to Cut Diagnosis Delays and Demand Better Endometriosis Care
Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells
Telomir-1 Inhibits Tumor Growth, Suppresses Cancer Progression, and Neutralizes Chemotherapy Toxicity
With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in Place, Biodexa is on Track to Initiate its Funded Phase 3 Trial in FAP Next Quarter
CARDIFF, UNITED KINGDOM / ACCESS Newswire / March 19, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is making progress in readying the launch of a phase 3 trial for eRapa, its proprietary encapsulated form of rapamycin being developed for the treatment of familial adenomatous polyposis (FAP).
Interactive Strength Inc. (Nasdaq:TRNR) Issues Shareholder Update on Positive Developments
Company Executes Against M&A Plan, Reiterates $50M+ Pro Forma Guidance, Additional $15M+ Revenue Deal that is expected to increase guidance; Institutional Investor Backing, Exclusive Distribution Agreements & Repeat Sales
Specificity, Inc. (SPTY) Continues to Evolve Its Proprietary In-Market Marketing Strategy, Fueled by Daily Nationwide Intent Feeds and Cutting-Edge Ad Tech
Specificity, Inc. (SPTY) Expands Its Proprietary In-Market Marketing Strategy—Now Powering Social and Display Ads with the Same High-Intent Audiences It Delivers
Global Licensing Group Launches Licensing Unlocked, a Revolutionary Education and Accreditation Tool for the Licensing Industry
LONDON, UK / ACCESS Newswire / March 19, 2025 / The Global Licensing Group at Informa Markets, the premier destination for advancing the business of licensing, brand extension and collaborations, today announces its brand-new educational program, Licensing Unlocked. In partnership with Licensing International, Licensing Unlocked is the first program of its kind to offer online educational sessions live and on-demand to bridge the knowledge gap for industry newcomers and provide ongoing education and accreditations for seasoned professionals.
No 'medical items' around Maradona deathbed, policeman tells court
A policeman who was among the first on the scene of Diego Maradona's death four years ago, told a court Tuesday he saw no "medical items" in the room where the football legend was receiving post-operative care at home.
Pain and anger grip N. Macedonia after fire tragedy
Despair mixed with anger at corruption in Kocani, North Macedonia on Tuesday in the wake of a nightclub fire that left dozens dead and more injured, prompting demands for justice.
Hungary passes bill against annual Budapest Pride march
Hungarian lawmakers passed a bill on Tuesday aimed at banning Budapest's annual Pride march, the latest in a series of measures under Prime Minister Viktor Orban's government, which critics say curtail the rights of the EU country's LGBTQ community.
French male film stars tell #MeToo inquiry about 'clumsy' remarks
Some of France's biggest male movie stars have testified at a parliamentary inquiry into sexual violence in the film business, saying they might have missed or even been guilty of inappropriate remarks before the #MeToo movement changed attitudes.
Leap of faith for Ubisoft with 'Assassin's Creed' set in Japan
Packing familiar formulas into an all-new Japanese setting, "Assassin's Creed Shadows" is the latest big-budget game from developer Ubisoft that is staking its future on the title.
Pain and anger grip N. Macedonia town after fire tragedy
Despair mixed with anger in Kocani, North Macedonia on Tuesday in the wake of a horrific nightclub fire that left dozens dead and even more injured, prompting demands for justice.
French hunter on trial for killing mother bear 'in self-defence'
A 81-year-old French hunter went on trial on Tuesday, accused of killing an endangered female bear that had attacked him in the Pyrenees.
AI 'reshaping' organised crime, warns Europol
Artificial intelligence is turbocharging organised crime, from creating child sexual abuse images to money laundering via cryptocurrency, Europol warned Tuesday, with advances like quantum computing only poised to make things worse.
Paris police evict migrants from theatre after months-long occupation
Police on Tuesday evacuated hundreds of young migrants from a central Paris theatre they had occupied for months, AFP journalists said.
US to execute four Death Row inmates this week
A 46-year-old man convicted of rape and murder is to be put to death by nitrogen gas in the southern state of Louisiana on Tuesday, the first of four executions scheduled this week in the United States.
Australia slams reported targetting of citizen by Hong Kong
Australia voiced unease on Tuesday over anonymous letters reportedly offering hefty rewards for information on a Hong Kong activist now living in Melbourne.
'We will preserve them': saving Cambodia's crocodiles
A motorbike rider inches slowly over bumpy terrain deep in Cambodia's Virachey national park, carefully adjusting the basket strapped behind him. Inside is precious cargo -- a critically endangered Siamese crocodile.
Japan victims voice fears 30 years after sarin subway attack
Three decades since Shizue Takahashi's husband and a dozen others were killed with a nerve agent on Tokyo's subway, she fears Japan could see a repeat of the doomsday cult attack.
Game On: Everything Sports at NAB Show - From Elite Keynotes to Cutting-Edge Tech and Immersive Activations
Inside the Future of Sports Media With Power Players Including ESPN, Formula 1, NFL, WTA, WWE and More
International Roofing Expo Unveils Winners of the 2025 Innovative Product Showcase and Awards Program
The second iteration of IRE awards celebrate cutting-edge developments in materials, equipment, tools and services that are revolutionizing roofing and exterior construction for businesses, laborers, commercial and residential.
Gaucho Group Holdings, Inc. Announces Settlement Term Sheet and Plan for Structured Exit from Chapter 11
Agreement Provides for Structured Settlement and Dismissal of Litigation
Exousia Has Successfully Renegotiated Its License Agreement
ORLANDO, FL / ACCESS Newswire / March 18, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is pleased to announce it has successfully renegotiated the license agreement it acquired with Progenicyte of Japan.
Dolphin Agencies Showcase Key Clients and Projects at 2025 SXSW Festival
MIAMI, FL / ACCESS Newswire / March 18, 2025 / Dolphin (NASDAQ:DLPN), a leading entertainment marketing and content production company, today announced the prominence of its subsidiaries-42West, Shore Fire Media, The Door, and The Digital Dept.-at the 2025 SXSW Festival in Austin, Texas. Recognized as the 2025 Agency of the Year by Observer, Dolphin's agencies represented clients and projects in multiple festival categories, including Film & TV, Music, and Conference programming.
Enable Me, the Florida Based Healthcare and Mobility Appliance Firm, Chosen by Pajunk USA to Market the Unique Stim2Go App-Controlled, Portable Electrical Stimulation Rehabilitation System
Stim2Go is one of the many healthcare enhancing products included in the neurology/neurorehabilitation portfolio of German firm Pajunk GmbH, celebrating its 60th anniversary this year.
Kelly's Opens Fifth Florida Location at Gateway Shoppes at North Bay in Naples
Boston's Legendary Roast Beef & Seafood Restaurant Further Expands Beloved Brand in Florida
Be Part of Something Bigger: viemaa tribe Is Live!
viemaa tribe: A Revolutionary Hair Care Community Dedicated to Empowering Healthy, Beautiful Hair
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously announced, oral DehydraTECH-tirzepatide also reduced adverse events by 47% compared to injected Zepbound®Lexaria's oral capsules worthy of expanded investigation as a viable alternative to injected tirzepatide.
Jaguar Health, Inc. Announces Reverse Stock Split
Reverse split approved at March 2025 Special Meeting of StockholdersShares of Jaguar Health common stock to begin trading on split-adjusted basis on March 24, 2025
Global Licensing Group Retail Programs Unlock Revenue Potential through Strategic Licensing Initiatives
Retailers are encouraged to apply to participate in retail mentoring initiatives and in-person conferences produced by the Global Licensing Group.
Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy
Continues focus on development of bispecific anti-cancer agents with differentiated mechanisms of action
Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain
~ Analgesic Experts Consider Pain Indications Versus New Classes of Analgesics ~~ Panel Discussion Posted to Ensysce's Corporate Website ~